Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Avidity Biosciences
Avidity Biosciences
Early data for Avidity's RNA therapy show possible functional benefit in muscular dystrophy
Fierce Biotech
Wed, 06/12/24 - 11:19 pm
Avidity Biosciences
RNA
AOC 1020
del-brax
FSHD
clinical trials
5 DMD Data Readouts to Watch in 2024
BioSpace
Mon, 05/6/24 - 11:24 am
DMD
clinical trials
Pfizer
gene therapy
fordadistrogene movaparvovec
Dyne Therapeutics
DYNE-251
Edgewise Therapeutics
EDG-5506
Capricor
CAP-1002
Avidity Biosciences
AOC 1044
Top five biopharma companies hiring in San Diego
BioSpace
Thu, 04/11/24 - 10:55 am
San Diego
biotech
hirings
Avidity Biosciences
Element Biosciences
AnaptysBio
Fate Therapeutics
Takeda
BMS, Avidity add another link to cardiovascular partnership with $100M expansion
Fierce Biotech
Tue, 11/28/23 - 10:29 am
Bristol Myers Squibb
Avidity Biosciences
R&D
cardiovascular disease
A new delivery method muscling its way into the RNA space
Pharma Voice
Thu, 11/9/23 - 09:41 am
Avidity Biosciences
RNA
drug delivery
Avidity unveils positive topline data from DM1 therapy trial
Clinical Trials Arena
Fri, 04/28/23 - 10:10 am
Avidity Biosciences
AOC 1001
clinical trials
myotonic muscular dystrophy
Avidity clamors for $150M raise on heels of positive data readout
Endpoints
Thu, 12/15/22 - 11:04 am
Avidity Biosciences
AOC-1001
RNA
Avidity Biosciences Stock Soars On New RNA Data
BioSpace
Wed, 12/14/22 - 07:21 pm
Avidity Biosciences
RNA
AOC-1001
myotonic muscular dystrophy
FDA Hits Avidity's AOC for Myotonic Dystrophy Type 1 with Partial Hold
BioSpace
Wed, 09/28/22 - 10:38 am
Avidity Biosciences
AOC 1001
myotonic muscular dystrophy
FDA
clinical trials
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
Fri, 06/19/20 - 11:27 am
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
Endpoints
Fri, 06/12/20 - 10:43 am
biotech
IPOs
Generation Bio
Avidity Biosciences
Vaxcyte
Burning Rock
Two preclinical biotechs riding the IPO wave this week look to raise $466M-plus
Endpoints
Thu, 06/11/20 - 11:11 am
IPOs
Avidity Biosciences
Generation Bio
JP Morgan Preview: Small, Medium and Large, with a Lot of M&A Speculation
BioSpace
Mon, 01/13/20 - 11:08 am
JPMHC 2020
M&A
Exelixis
Intercept Pharmaceuticals
Avidity Biosciences
Theravance
Moderna Therapeutics
Kodiak Sciences